LSU Health Shreveport researchers recently presented preliminary findings at the American Heart Association’s Basic Cardiovascular Sciences 2019 Scientific Sessions that use of the illegal stimulant methamphetamine causes build-up of tough protein fibers in heart muscle, which may help explain the development of enlarged hearts and heart failure in users.
A paper authored by many researchers at LSU Health Shreveport on the prevention and treatment of stroke was recently published in Circulation, a journal of the American Heart Association.
The LSU Health Shreveport Department of Molecular & Cellular Physiology and Aphios Corporation have obtained United States Patent No. 9,994,585 entitled “Transplantation Therapies,” for marine pharmaceutical ‘Bryostatin-1,’ which will be used as an additive to organ transport and storage solutions.
- Zaki Al-Yafeai Awarded American Heart Association Fellowship
- Physiology Graduate Students Receive Malcolm-Feist Fellowships
- Mansoureh Barzegar Receives Travel Award
Congratulations to Physiology graduate students, Gaganpreet Kaur and Mansoureh Barzegar! They have been awarded Malcolm-Feist Pre-Doctoral Fellowships by the Center for Cardiovascular Diseases and Sciences. Ms. Kaur's grant is entitled, "The Structure and Function of the Endothelial Glycocalyx in Diabetic Retinopathy". Ms. Barzegar's grant is entitled, "hPMSC exosome-ACE2 dependent protection in stroke injury : Role of Mas Receptor and AT2 Receptor".
Mansoureh Barzegar received the Inaugural William Halpern travel award from Microcirculatory Society which was given to the top scored applicant. The award consists of a certificate and $750. Ms. Barzegar presented her work at the annual Microcirculatory Society Poster Session on April 10th, 2019 in Orlando, Florida. The title of her presentation was: "Human placental mesenchymal stem cell therapy in stroke: endothelial/smooth muscle mechanisms underlying protection".